Pulse Biosciences, Inc (NASDAQ:PLSE) is set to announce third quarter earning results on Monday 9th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, PLSE to report 3Q20 loss of $ 0.44 per share.
For the full year, analysts anticipate loss of $ 1.98 per share bottom line.
Stock Performance
On Friday, shares of Pulse Biosciences, Inc has traded high as $ 12.47 and has cracked $ 11.95 on the downward trend, reaching $ 12.15 with volume of 60.20 thousand shares.
According to the previous trading day, closing price of $ 12.15, representing a 135.03 % increase from the 52 week low of $ 5.11 and a 32.41 % decrease over the 52 week high of $ 17.77.
The company has a market capital of $ 306.33 million and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
Pulse Biosciences, Inc will be hosting a conference call at 4:30 PM eastern time on 9th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.pulsebiosciences.com
Pulse Biosciences, Inc. operates as a clinical stage medical therapy company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications.
